coronavirus bioweapon.pptx

Coronavirus
Bioweapon – How
China Stole
Coronavirus from
Canada And
Weaponized It

The findings of this
investigation has been
corroborated by none other
than the Bioweapons expert
Dr. Francis Boyle who drafted
the Biological Weapons
Convention Act followed by
many nations. The report has
caused a major international
controversy and is suppressed
actively by a section of
mainstream media.

Francis Boyle is a professor of international law at the University of Illinois
College of Law. He drafted the U.S. domestic implementing legislation for
the Biological Weapons Convention, known as the Biological Weapons
Anti-Terrorism Act of 1989, that was approved unanimously by both
Houses of the U.S. Congress and signed into law by President George H.W.
Bush.
Last year a mysterious shipment was caught smuggling Coronavirus from
Canada. It was traced to Chinese agents working at a Canadian lab.
Subsequent investigation linked the agents to Chinese Biological Warfare
Program from where the virus is suspected to have leaked causing the
Wuhan Coronavirus outbreak.

This Photo by Unknown Author is licensed under CC BY-SA
Highlights: -
● How the Deep State deployed anthrax on US soil to whip up publicity about biological
weapons and increase funding for bioweapons labs
● Why the WHO and CDC are both criminal organizations which are complicit in the
covert development of biological weapons
● The “death science” industry and why the US government has spent over $100 billion
developing self-replicating weapons
● Details about the Pirbright Institute and its ties to bioweapons, depopulation, vaccines
and coronavirus patents. (It’s partially funded by Bill & Melinda Gates)
● How Chinese Biowarfare agents working at the Canadian lab in Winnipeg were involved
in the smuggling of Coronavirus to Wuhan’s lab from where it is believed to have been
leaked.
● Why all BSL-3 and BSL-4 labs in the world should be banned and shut down.

There are some people in the US and experts that have been saying that in reality,
China isn’t complying with the Bioweapons convention. Is China developing its own
biosafety level four lab in Wuhan and elsewhere, as you know, as a type of deterrence.
Is it a type of a biological arms race that we have going on? what do you make of
reports that Chinese scientists have been stealing research and viruses, including
the coronavirus from a Canadian bio lab this past December? Chinese nationals have
been charged with smuggling vials of biological research to China from the US with the
aid of Charles Lieber who was the chair of Harvard’s chemistry department. And he also
happens to be in 2011 a strategic scientist at Wuhan University. What’s going on with
this recent outbreak in Wuhan?

Basically BSL-4 labs are used to develop offensive
biological warfare weapons with DNA genetic engineering.
Wuhan has a BSL-4 laboratory. they were researching
SARS, and they weaponize it further by giving it a gain of
function properties, which means it could be more lethal.
Indeed, the latest report now is it’s a 15% fatality rate,
which is more than SARS at 83% infection rate. A typical
gain of function travels in the air so it could reach out
maybe six feet or more from someone emitting a sneeze or
a cough. Likewise, this is a specially designated WHO
research lab. The WHO was in on it, and they knew full
well what was going on there. The coronavirus that we’re
dealing with here is an offensive biological warfare
weapon that leaped out of Wuhan BSL-4.

It’s also been
reported that
Chinese scientists
stole coronavirus m
aterials from the
Canadian lab at
Winnipeg. Winnipeg
is Canada’s formal
center for research,
developing, testing,
biological warfare
weapons. It’s along
the lines of Fort
Detrick here in the
United States of
America.

All these BSL-4 labs are by United
States, Europe, Russia, China, Israel are
all there to research, develop, test
biological warfare agents. There’s really
no legitimate scientific reason to have
BSL-4 labs. They’re complete unsafe.
BSL-3 and BSL-4 lab are only designed
for research development testing of
offense of biological warfare
agents. They serve no legitimate
purpose at all. They should all be shut
down, every one of them.

They’re simply too dangerous.
There’s an excellent documentary
called Anthrax Wars by Nadler and
Coen. Basically, this is offensive
biological weapons raised by the
United States government and
with its assistance in Canada and
Britain. The world responded
accordingly including Russia and
China. They were going to set up a
whole series of BSL-4 facilities as
well. Wuhan was the first. It
backfired on them.
This Photo by Unknown Author is licensed under CC BY-NC-ND

It does appear they stole
something there from
Winnipeg. This activity that
they engaged in clearly
violates the Biological
Weapons Convention.
Research development of
biological weapons these days
is an international crime, the
use of it would be. That was
criminal. Wuhan BSL-4 was
research developing, testing,
SARS as a biological warfare
agent. So, it could have been,
they gave it this DNA genetic
engineering enhanced
properties gain of function.
All these BSL-4 facilities
leak. Everyone knows that
who studies this. So, this was
a catastrophe waiting to
happen. Unfortunately, it
happened.

The Chinese government under Xi and his comrades there have
been covering this up from the get-go. The first reported case
was December 1, so they’d been sitting on this until they couldn’t
anymore. And everything they’re telling you is a lie. It’s
propaganda. The WHO was in on it. They’ve approved many of these
BSL-4 labs., they know exactly what’s going on and that is a WHO research-
approved laboratory. They know what’s going on too. You can’t really
believe anything the WHO is telling you about this, either they’re
up to their eyeballs in it.
This Photo by Unknown Author is licensed under CC BY

During the 2009 swine flu, which didn’t have too
many casualties, but profited greatly the
pharmaceutical companies. Back in 2009, many
countries purchased great stocks of the
vaccines and they ended up not using
anywhere from 50 to 80% of the vaccines that
they purchased. The World Health
Organization is a front for Big Pharma. Robert
F. Kennedy Jr. also agrees 50% of WHO
funding comes from pharmaceutical
companies. And that the CDC itself is also
severely compromised.

There was also the report that there
was a consortium of companies which
included the Gates foundation that
back in just two or three months ago in
October of 2019 they held a pandemic
exercise simulating an outbreak. I
mean, what are the chances specifically
of a coronavirus and it was called
events 201. People can find this online
and they gave a list of seven
recommendations for governments
and international organizations to
take. I also find that kind of interesting
how they had this simulation.

The Bill & Melinda Gates fund
this type of DNA genetically
engineered biological warfare
work. So, you can’t trust
anything they’re telling you that
somehow, they’re out there
trying to make the world a better
place. We have Bill Gates
publicly admitting that the
world be a better place if there
were a lot less people. So, the
Bill & Melinda Gates foundation,
they are wolves in sheep’s
clothing and they are funding
this type of stuff.

From Robert F. Kennedy Jr.'s
Instagram post, April 9th, 2020:
"Vaccines, for Bill Gates, are a
strategic philanthropy that feed
his many vaccine-related
businesses (including
Microsoft’s ambition to control a
global vac ID enterprise) and
give him dictatorial control over
global health policy—the spear
tip of corporate neo-
imperialism. Gates’ obsession
with vaccines seems fuelled by a
messianic conviction that he is
ordained to save the world with
technology and a god-like
willingness to experiment with
the lives of lesser humans.

Visit this Link to read- Original deleted post on Archive Robert. F. Kennedy. Jr
https://archive.ph/oNRO6

Promising to eradicate Polio with $1.2
billion, Gates took control of India ‘s
National Advisory Board (NAB) and
mandated 50 polio vaccines (up from 5)
to every child before age 5. Indian
doctors blame the Gates campaign for a
devastating vaccine-strain polio
epidemic that paralyzed 496,000
children between 2000 and 2017. In
2017, the Indian Government dialled
back Gates’ vaccine regimen and evicted
Gates and his cronies from the NAB.
Polio paralysis rates dropped
precipitously. In 2017, the World Health
Organization reluctantly admitted that
the global polio explosion is
predominantly vaccine strain, meaning
it is coming from Gates’ Vaccine
Program. The most frightening
epidemics in Congo, the Philippines, and
Afghanistan are all linked to Gates’
vaccines. By 2018, ¾ of global polio
cases were from Gates’ vaccines.

In 2014, the Gates Foundation funded tests of experimental
HPV vaccines, developed by GSK and Merck, on 23,000
young girls in remote Indian provinces.

Approximately 1,200 suffered severe side effects, including autoimmune
and fertility disorders, seven died. Indian government investigations
charged that Gates funded researchers committed pervasive ethical
violations: pressuring vulnerable village girls into the trial, bullying
parents, forging consent forms, and refusing medical care to the injured
girls. The case is now in the country’s Supreme Court.

During Gates 2002 MenAfriVac
Campaign in Sub-Saharan Africa,
Gates operatives forcibly
vaccinated thousands of African
children against meningitis.
Between 50-500 children
developed paralysis. South African
newspapers complained, “We are
guinea pigs for drug makers”
Nelson Mandela’s former Senior
Economist, Professor Patrick
Bond, describes Gates’
philantropic practices as “ruthless”
and “immoral”.

In 2010, Gates committed $10
billion to the WHO promising to
reduce population, in part,
through new vaccines. A month
later Gates told a Ted Talk that
new vaccines “could reduce
population”. In 2014, Kenya’s
Catholic Doctors Association
accused the WHO of chemically
sterilizing millions of unwilling
Kenyan women with a phony
“tetanus” vaccine campaign.
Independent labs found the
sterility formula in every vaccine
tested. After denying the charges,
WHO finally admitted it had
been developing the sterility
vaccines for over a decade.

Similar accusations came from
Tanzania, Nicaragua, Mexico and the
Philippines.
A 2017 study (Morgensen et.Al.2017)
showed that WHO’s popular DTP is
killing more African than the disease
it pretends to prevent. Vaccinated
girls suffered 10x the death rate of
unvaccinated children. Gates and the
WHO refused to recall the lethal
vaccine which WHO forces upon
millions of African children annually.

Global public health advocates
around the world accuse Gates
of – hijacking WHO’s agenda
away from the projects that are
proven to curb infectious
diseases; clean water, hygiene,
nutrition and economic
development.
They say he has diverted
agency resources to serve his
personal fetish – that good
health only comes in a syringe.

In addition to using his philanthropy to control WHO, UNICEF, GAVI and PATH,
Gates funds private pharmaceutical companies that manufacture vaccines, and a
massive network of pharmaceutical industry front groups that broadcast
deceptive propaganda, develop fraudulent studies, conduct surveillance and
psychological operations against vaccine hesitancy and use Gates’ power and
money to silence dissent and coerce compliance.
In this recent nonstop Pharmedia appearances, Gates appears gleeful that the
Covid-19 crisis will give him the opportunity to force his third-world vaccine
programs on American children.”
There is so much more info out there about this evil man if you are willing to
look. He is not a philanthropist, scientist or doctor; he is a psychopath.

Swine flu is a genetically modified
biological warfare weapon. It was a
chimera of three different types of
genetic strains that someone put it
together in a cocktail. Fortunately, it was
not as lethal. The Pirbright Institute in
Britain that’s tied into their biological
warfare program over there. They were
behind the hoof and mouth disease
outbreak over there that wiped out their
cattle herd and it leaked out of there. So
it’s clear they’re working on a hoof and
mouth biological warfare weapon, but
the vaccine is there.

The only reason they develop
these biological weapons to
eventually be used. And also,
these can be used covertly.
see an unexplained sudden
a disease like this anywhere in
world, both for human beings
animals, you can always suspect
warfare agent is at work. These
more exotic things, there are
stockpiles. Basically after 9/11,
2001, that entire industry –
biological warfare industry has
reconstituted here in the United
with all these BSL-4 BSL-3 labs,
over 13,000, alleged scientists
on these things.

There was a Russian double agent spy Sergei Skripal who had been allegedly poisoned with Novichok
out in Britain. It just so happened where he was allegedly poisoned, by a a nerve agent called DX he
was right in Porton down the British bio weapons lab, right down the street from Porton Down, the
world’s first bio weapons lab that was created in 1916.
Have you wondered if this new war for biotechnological dominance, can also be used kind of as a
pretext for the centralization of political power and the initiation of wars like the 2003 Iraq war? Is
this another danger that we get these events like now this coronavirus and then governments will call
for a centralization of greater power and taking away some of our civil liberties?

If you look at the October, 2001
anthrax attacks here in the
United States, that was clearly
by elements of the United States
government that was behind
that. That was a super weapons
grade anthrax with a trillion
spores per gram and it floated in
the air solely a very
sophisticated biological weapons
lab like Fort Detrick could
produce that. Fort Dietrich
made the dugway proving
ground still has a stockpile of
that super weapons grade
anthrax that we saw in October
of 2001. And they use that
anthrax attack including on
Congress to brand through the
USA Patriot act which basically
turned the United States to a
police state.

This Wuhan Virus is a DNA genetically engineered biological warfare agent
leaking out of Wuhan that has gain-of-function properties which can make it
more lethal. They are probably doing something with SARS to make it a lot
more lethal and more infectious.

And so, for that reason, you have to take extreme precautions and they’re now
finally admitted anyone within six feet can be infected, whereas with SARS that
was about two feet. Well, that’s gaining a function right there and that should be a
tip off. I think you’ve got to stay at least six feet away because this is gained
function. It can flow through the air and infect, and it can get you in the eyes. Any
orifice, the mouth, maybe the ears, we’re not sure at this point. Those medical
checks are worthless because this is just public relations by all the governments
involved because there is a 14 day incubation period where people can still be
infected.

So, someone could walk right
through a medical inspection and
passing a gate into your country and
then they come down with
the coronavirus. So that’s all public
relations in my opinion by
governments and they know it and
they’re just sending people out there
with temperatures guns and things
like that. It’s not like SARS, this is
more dangerous than SARS.

Wuhan lab had SARS in
there that they were
dealing with, and they
enhanced it at
and that’s what we’re
dealing with. taking
high doses of vitamin C
and other things like
this can help you.
Pirbright vaccine has
been patented that that
might work. There is
risk in taking any of
these other vaccines.

No, you have no idea what’s in there.
for this vaccines (these DNA genetic
engineered vaccines) they’ll be using
live coronavirus probably and
sticking it in there and giving you
some live coronavirus on the theory
you’ll develop an immunity. That’s
the way a lot of these vaccines
worked out, that’s what happened
with the Ebola vaccine that created
the Ebola pandemic there in West
Africa. They were testing out a
vaccine on poor black Africans, as
usual, and this vaccine had live
Ebola in it so it gave them
Ebola. You’ll be the Guinea pig for
big pharma and everyone figures
they’re going to make a lot of money
here.

• The Saudi SARS Sample
• The Canadian Lab
• Chinese Biological Espionage
• Xiangguo Qiu – The Chinese Bio-Warfare Agent
• Infiltrating the Canadian Lab
• The Wuhan Coronavirus
• Coronavirus Bioweapon
• China’s Biological Warfare Program
• Weaponizing Biotech
• GreatGameIndia Coronavirus Coverage

The Saudi SARS Sample
On June 13, 2012 a 60-year-old Saudi man was admitted to a
private hospital in Jeddah, Saudi Arabia, with a 7-day history
of fever, cough, expectoration, and shortness of breath. He had
no history of cardiopulmonary or renal disease, was receiving
no long-term medications, and did not smoke.
Egyptian virologist Dr. Ali Mohamed Zaki isolated and
identified a previously unknown coronavirus from his lungs.
After routine diagnostics failed to identify the causative agent,
Zaki contacted Ron Fouchier, a leading virologist at the
Erasmus Medical Center (EMC) in Rotterdam, the
Netherlands, for advice.

Fouchier sequenced the
virus from a sample
sent by Zaki. Fouchier
used a broad-spectrum
“pan-coronavirus” real-
time polymerase chain
reaction (RT-PCR)
method to test for
distinguishing features
of a number of known
coronaviruses known to
infect humans.
Abnormalities on Chest Imaging of the
Saudi patient infected with
Coronavirus. Shown are chest
radiographs of the patient on the day of
admission (Panel A) and 2 days later
(Panel B) and computed tomography
(CT) 4 days after admission (Panel C)

This Coronavirus sample was
acquired by Scientific Director Dr.
Frank Plummer (key to Coronavirus
investigation Frank Plummer was
recently assassinated in Africa) of
Canada’s National Microbiology
Laboratory (NML) in Winnipeg directly
from Fouchier, who received it from
Zaki. This virus was reportedly stolen
from the Canadian lab by Chinese
agents.
Frank Plummer - renowned Winnipeg
based Canadian National Microbiology
Laboratory scientist key to
Coronavirus investigation has died in
mysterious conditions in Africa. He was
the one who received Saudi SARS
Coronavirus sample which was
smuggled to Wuhan.

The National Microbiology Lab (The Canadian Science Centre
for Human and Animal Health) on Arlington St. in Winnipeg.
Wayne Glowacki/Winnipeg Free Press Oct.22 2014

The Canadian Lab
Coronavirus arrived at Canada’s NML Winnipeg facility on May 4, 2013
from the Dutch lab. The Canadian lab grew up stocks of the virus and used
it to assess diagnostic tests being used in Canada. Winnipeg scientists
worked to see which animal species can be infected with the new virus.
Research was done in conjunction with the Canadian Food Inspection
Agency’s national lab, the National Centre for Foreign Animal Diseases
which is housed in the same complex as the National Microbiology
Laboratory. NML has a long history of offering comprehensive testing
services for coronaviruses. It isolated and provided the first genome
sequence of the SARS coronavirus and identified another coronavirus NL63
in 2004.
This Winnipeg based Canadian lab was targeted by Chinese agents in what
could be termed as Biological Espionage.

Chinese Biological Espionage
China's Biological Warfare Program is believed to include full
range of traditional chemical & biological agents with a wide
variety of delivery systems including artillery rockets, aerial
bombs, sprayers, and short-range ballistic missiles.
China’s Biological Warfare Program is believed to be in an
advanced stage that includes research and development,
production and weaponization capabilities. Its current
inventory is believed to include the full range of traditional
chemical and biological agents with a wide variety of delivery
systems including artillery rockets, aerial bombs, sprayers,
and short-range ballistic missiles.

A combination of past and present geostrategic factors distinctly affect the Chinese approaches
and outlooks with regard to Biological Warfare. The first major factor is the relapsing Japanese
Biological Warfare attacks against and human Biological Warfare experimenting on Chinese
populations, which took place from 1933 to 1945, killing and injuring tens of thousands, without
the Chinese being able to cope or retaliate.

The employment of
Biological Warfare
against the Chinese by
the Japanese military
had a long-lasting
impact in China. The
Chinese official news
agency, Xinhua, reported
in 2002, that ‘at least
270,000 Chinese soldiers
and civilians were
slaughtered by Japanese
germ-warfare troops
between 1933 and 1945’,
according to an ‘in-depth
study by Chinese and
Japanese scholars.’

The second factor is the Chinese belief (whether sound or unsound) that the United
States (US) conducted Biological Warfare offensive operations in China (and North
Korea) during the Korean War (1950–53), alongside with the evident fact that
between 1950 and 1972, the US possessed an operational Biological Warfare arsenal.

The third factor concerns the then Union of Soviet Socialist Republics (USSR). Allegedly, near
the end of World War II, USSR conducted experiments with plague, anthrax and cholera in
Soviet-occupied Mongolia. Later on, tests with various vaccines were conducted by the USSR in
Mongolia for a long period of time, concomitantly with the persisting communist brotherhood
between China and USSR and their strategic cooperation in general, and Chinese awareness
and following (to a certain extent) of the colossal Biological Warfare program run by the USSR
in particular.

A comprehensive study of the aspects
pertaining to those geostrategic factors was
published in 1999—entitled China and Weapons
of Mass Destruction: Implications for the
United States—within the framework of a
conference sponsored by the US National
Intelligence Council and Federal Research
Division.

Collectively, these solidly formed
Chinese perspectives shaped the
People’s Liberation Army’s (PLA)
approaches and outlooks
pertaining to Biological Warfare,
and yielded, naturally, a wide
Chinese Biological Warfare
Program which still persists fully
viably—if appreciably
concealed—and comprises both
defensive and offensive sub-
programs. Often located and
working conjunctively, each of
the two sub-programs, however,
constitutes a strategically
distinct entity.

During the Korean War
(1950–53), the earliest
semblance of routinized
defence against Biological
Warfare in the PLA were the
1952 sanitation/anti-plague
units, formed through the
involvement of the Chinese
People’s Volunteer Army in
Korea. At the same time,
intensive educational
campaigns to rid disease-
carrying pests were
conducted, combined with
experience of supposed
Biological Warfare casualties
treated during the Korean
War.

Consequently, in 1954, PLA
delegations and students visited
the USSR for training in
microbiology and infectious
diseases. Officially, China
declared that its BWs defence
programme was initiated in 1958.
It was based on a network of anti-
plague stationary and mobile
facilities (similar to the Soviet
one), aiming to cope with plague
and further hazardous infectious
diseases.

The defensive programme had
considerably been evolving during the
1960s, while an offensive Biological
Warfare program was initiated in
conjunction. By the mid-1970s, a
comprehensive, orderly defensive
alignment had been already operating
within China’s Biological Warfare
Program, while an effective offensive
BW program was run concurrently.

The latter was formed as an
outcome of the influential
geostrategic factors mentioned
earlier, yet, presumably, was no
less a result of an innate Chinese
will to possess an arm of high
strategic value, in terms of sub-
nuclear weapons of mass
destruction (WMD). Such motive
seems to typically reside in the
Chinese national outlook
regarding nearly any advanced
weaponry.

China joined the Biological
Weapons Convention (BWC) in
1984, 12 years after the
Convention was opened for
signature by the international
community. China acceded to
the BWC in 1984, but in a
report entitled Adherence to
and Compliance with Arms
Control Agreements, the US
Arms Control and
Disarmament Agency
contended: ‘China maintained
an offensive biological
weapons program throughout
the 1980s. The program
included the development,
production, stockpiling or
other acquisition or
maintenance of biological
warfare agents.’

The Pentagon also published a similar paper, entitled ‘Proliferation:
Threat and Response’, which claimed that China’s Biological Warfare
Program includes manufacturing of infectious microorganisms and
toxins. In 1993, US intelligence officials stated that it was highly
probable that China had an active and expanding offensive BWs
program, following assessment that two civilian-run biological
research centres were actually controlled by the Chinese military.

The research centres were
known to have engaged
previously in production
and storage of BW. The
American suspicions
intensified in 1991 when
one of the suspected
biological centres was
enlarged. Suspicions
heightened further after
Beijing made, according to
a US official, a ‘patently
false’ declaration to the
United Nations (UN) that
it had never made any
germ weapons or
conducted any work to
bolster defences against a
biological attack.

The Chinese Foreign Ministry
subsequently described all this as
groundless, denying that China had a
germ weapons programme. In 1995,
President Clinton transmitted to the US
Congress his statutory annual
report, Adherence to and Compliance with
Arms Control Agreements. On China, it
said:
‘[T]here are strong indications that China
probably maintains its offensive BW
program.’ In its Chemical and Biological
Defense Program Annual Report and the
Chemical and Biological Defense Program
Performance Plan for 2001, the US
Department of Defense was even more
specific, contending: ‘China possesses
the munitions production capabilities
necessary to develop, produce and
weaponize biological agents’.

Convening a hearing on China’s proliferation practices in 2003, the
US–China Economic and Security Review Commission was
informed as follows:
The US believes that despite being a member of the Biological
Weapons Convention, China maintains a BW program in violation
of its BWC obligations. The United States believes that China’s
consistent claims that it has never researched, produced or
possessed BW are simply not true, and that China still retains its
BW program.
Although China has submitted its voluntary annual BWC
confidence-building measure (CBM) data declarations every year,
the US Department of State assessed in 2005 that the information
submitted therein continued to be ‘inaccurate and misleading’.
Further, ‘BWC CBMs since 1991 have called on the States Parties
to declare, among other things, their past offensive activities, which
China has not done. On the contrary, China insists it never had
such a program at all.’

Likewise, in 2007, Defense
Intelligence Agency (DIA)
testimony for the US Senate, the
Select Committee on Intelligence,
entitled ‘Current and Projected
National Security Threats’ (in both
open and closed sessions),
contended that the DIA believes
China ‘continues to maintain some
elements of an offensive biological
weapons program.’

The Central Intelligence Agency (CIA), the DIA and intelligence
agencies in other countries most probably continue to carefully follow
and monitor China’s Biological Warfare Program. Irrespective of
publicly bringing out their findings—if partially—or totally keeping
them, Beijing’s BWP entirely persists in all likelihood. It is assumed
that it includes an extremely secretive operational, sizable BW
arsenal, extremely hidden, which is steadily being upgraded.

From 1998 to
2009, two
waves
expressing
China’s
declared
attitude to the
BWC can be
observed.

The first one, from 1998 to 2002, was
apparently a result of increasing accusations
made by the US in regard to an ongoing
offensive Biological Warfare Program
conducted by Beijing. Unsurprisingly, the
first wave China generated within that
context begun with a ‘Joint Statement on
Biological Weapons Convention’, issued by
Presidents Jiang Zemin and Bill Clinton
during the Sino-US summit meeting that
took place in China in June 1998, as follows:
Recognizing the threat posed by biological
and toxin weapons, the United States and
China reaffirm their strong support for the
complete global elimination of biological
weapons. As States Parties to the Biological
Weapons Convention, the two sides stress
the importance of the Convention to
international peace and security, fully
support the purposes and objectives of the
Convention, and favor comprehensively
strengthening the effectiveness and
universality of the Convention.

Various further steps were taken
by China, so as to manifest a
supportive—if not entirely
favourable—attitude towards the
BWC. In its 17 October 2002
announcement on the
promulgation of ‘Regulations on
Export Control of Dual-use
Biological Agents and Related
Equipment and Technologies’,
China stated that it ‘has never
developed, produced or stockpiled
any biological weapons, and never
assisted any country to acquire or
develop these weapons.’

The second wave coincides
with the period 2006 to 2009,
widely accentuated by Chinese
diplomacy with respect to the
BWC. Once again, so it seems,
this was in response to
accumulating American
accusations regarding an
ongoing Biological Warfare
Program run by China.

The aspect of
widening cooperation
among state parties
was largely pointed at
as well by China, in
2007:
All States Parties should
make full use of the
Convention as an important
platform to strengthen
cooperation and
communication, promote
implementation and other
capacity of the Convention.
China believes that adopting
effective national
implementation measures in
accordance with the
Convention and respective
national situations
constitutes basic obligations
for the States Parties, as well
as the important prerequisite
and guarantee for effective
implementation of all articles
of the Convention.

In a white paper on China’s National Defence issued in 2008 by the Chinese
State Council, the chapter on arms control and disarmament emphasized
adherence to the BWC:
China observes in good faith its obligations under the BWC, and supports
the multilateral efforts aimed at strengthening the effectiveness of the
Convention. China has actively participated in the meetings of the parties
to the Convention and the meetings of experts in a pragmatic manner.
China has already established a comprehensive legislation system for the
implementation of the Convention, set up a national implementation focal
point, and submitted its declarations regarding confidence-building
measures to the Implementation Support Unit of the Convention in a timely
fashion.

In 2009, China accentuated its approach concerning Article X of
the BWC, noting, ‘All provisions including Article X of the
Convention are equally important and should be fully
implemented. To strengthen international cooperation helps
improve the implementation capability of States Parties,
promote the effectiveness of the Convention, and finally enhance
the universalization of the Convention.’

China also referred, in 2009, to the aspect of
tackling the spread of hazardous infectious
diseases as being closely related to the objectives
of the BWC: ‘Information about any outbreak of
acute infectious diseases should be shared in
accordance with the current practice of relevant
international organizations.’

The SARS Epidemic
Although the latter constitutes a self-evident
rule for long, the opposite conduct was
exhibited by China from November 2002—
when a sever acute respiratory syndrome
(SARS) epidemic broke out in the country—
till February 2003, when China reported it for
the first time to the World Health
Organization (WHO), disclosing the seriously
threatening event (the causative virus spread
from China to 37 countries) during three
months.

China declared that there is only
one biohazard installation with
maximal safety level (P4)
throughout the country, although
this is doubtful. Uniquely, across
China, and officially, the Wuhan
Institute of Virology is the sole
facility that is equipped with
such biohazard measure,
furnished by a French supplier.
The Institute investigates highly
virulent viruses, such as
SARS14, influenza H5N115,
Japanese encephalitis16, and
dengue. Besides this, the germ
causing anthrax is studied at the
Institute too (which is beyond the
discipline of virology).

During the last five years, China has reiterated various
BWC aspects and declarations it had previously
mentioned, as described. All in all, its diplomacy
regarding the BWC is consistent and noticeably in
favour of the Convention. And yet, it stands in
contradiction to the China’s Biological Warfare Program,
which is both defensive and offensive.

At any rate, China legitimately adheres, outwardly, to the requirements
posed by the BWC in terms of defensive profile and biosecurity
implementation. The relevance and characteristics of those aspects in
relation to China have been discussed in detail, fairly professionally, by
senior Chinese scientists within two notable reviews, forming,
nevertheless, a screen of vagueness over the core components of China’s
Biological Warfare Program, especially those dealing with bio-weaponry.

In March 2019, in mysterious
event a shipment of exceptionally
virulent viruses from Canada’s
NML ended up in China. The
event caused a major scandal
with Bio-warfare experts
questioning why Canada was
sending lethal viruses to China.
Scientists from NML said the
highly lethal viruses were a
potential bio-weapon.

Following investigation, the
incident was traced
to Chinese agents working
at NML. Four months later
in July 2019, a group
of Chinese virologists were
forcibly dispatched from the
Canadian National
Microbiology
Laboratory (NML). The
NML is Canada’s only level-
4 facility and one of only a
few in North America
equipped to handle the
world’s deadliest diseases,
including Ebola,
SARS, Coronavirus, etc.
Dr. Xiangguo Qiu, the Chinese Biological Warfare Agent working at
the National Microbiology Laboratory, Canada

The NML scientist who was escorted
out of the Canadian lab along with her
husband, another biologist, and
members of her research team is
believed to be a Chinese Bio-Warfare
agent Xiangguo Qiu. Qiu was the head
of the Vaccine Development and
Antiviral Therapies Section in the
Special Pathogens Program at
Canada’s NML.
Sources say Xiangguo Qiu and her husband Keding Cheng were escorted from the National Microbiology Lab
in Winnipeg on July 5, 2019. Since then, the University of Manitoba has ended their appointments,
reassigned her graduate students, and cautioned staff, students and faculty about traveling to China.

Xiangguo Qiu is an outstanding
Chinese scientist born in Tianjin.
She primarily received her
medical doctor degree from Hebei
Medical University in China in
1985 and came to Canada
for graduate studies in 1996.
Later on, she was affiliated with
the Institute of Cell Biology and
the Department of Pediatrics and
Child Health of the University of
Manitoba, Winnipeg, not engaged
with studying pathogens.

But a shift took place,
somehow. Since 2006, she
has been studying powerful
viruses in Canada’s NML.
The viruses shipped from
the NML to
China were studied by
her in 2014, for instance
(together with the viruses
Machupo, Junin, Rift Valley
Fever, Crimean-Congo
Hemorrhagic Fever and
Hendra).

Dr. Xiangguo Qiu is married to another
Chinese scientist – Dr. Keding Cheng, also
affiliated with the NML, specifically the
“Science and Technology Core”. Dr. Cheng is
primarily a bacteriologist who shifted to
virology. The couple is responsible for
infiltrating Canada’s NML with many Chinese
agents as students from a range of Chinese
scientific facilities directly tied to China’s
Biological Warfare Program, namely: -
1. Institute of Military Veterinary, Academy of
Military Medical Sciences, Changchun
2. Center for Disease Control and Prevention,
Chengdu Military Region
3. Wuhan Institute of Virology, Chinese
Academy of Sciences, Hubei
4. Institute of Microbiology, Chinese Academy
of Sciences, Beijing

All of the above four
mentioned Chinese Biological
Warfare facilities collaborated
with Dr. Xiangguo Qiu within the
context of Ebola virus, the Institute of
Military Veterinary joined a study on
the Rift Valley fever virus too, while
the Institute of Microbiology joined a
study on Marburg virus. Noticeably,
the drug used in the latter study –
Favipiravir – has been earlier tested
successfully by the Chinese Academy
of Military Medical Sciences, with the
designation JK-05 (originally a
Japanese patent registered in China
already in 2006), against Ebola and
additional viruses.

However, the studies by
Dr. Qiu are considerably
more advanced and
apparently vital for
the Chinese biological
weapons development in
case Coronavirus, Ebola,
Nipah, Marburg or Rift
Valley fever viruses are
included therein.

The Canadian investigation is
ongoing and questions remain
whether previous shipments to
China of other viruses or other
essential preparations, took place
from 2006 to 2018, one way or
another.
Dr. Xiangguo Qiu also
collaborated in 2018 with three
scientists from the US Army
Medical Research Institute of
Infectious Diseases, Maryland,
studying post-exposure
immunotherapy for two Ebola
viruses and Marburg virus in
monkeys; a study supported by
the US Defense Threat Reduction
Agency.
Dr. Gary Kobinger, former chief of special pathogens (right), and
Dr. Xiangguo Qiu, research scientist (second from right) met with Dr. Kent
Brantly and Dr. Linda Mobula, assistant professor at Johns Hopkins School
of Medicine and the physician who administered ZMapp to Brantly in
Liberia when he was infected with Ebola during the 2014-16
outbreak. (Submitted by Health Canada)

In a table-top pandemic exercise at Johns Hopkins
University last year, a pathogen based on the emerging
Nipah virus was released by fictional extremists,
killing 150 million people. A less apocalyptic scenario
mapped out by a blue-ribbon U.S. panel envisioned
Nipah being dispersed by terrorists and claiming over
6,000 American lives.
Scientists from Canada’s National Microbiology
Laboratory (NML) have also said the highly lethal bug
is a potential bio-weapon. But this March that same
lab shipped samples of the henipavirus family and of
Ebola to China, which has long been suspected of
running a secretive biological warfare program. “I
would say this Canadian ‘contribution’ might likely be
counterproductive,” said Dany Shoham, a biological
and chemical warfare expert at Israel’s Bar-Ilan
University. “I think the Chinese activities … are highly
suspicious, in terms of exploring (at least) those viruses
as BW agents.”

China strongly denies it
makes germ weapons, and
Canadian officials say the
shipment was part of its
efforts to support public-
health research
worldwide. Sharing of
such samples
internationally is
relatively standard
practice. But some experts
are raising questions
about the March transfer,
which appears to be at the
centre of a shadowy
RCMP investigation and
dismissal of a top scientist
at the Winnipeg-based
NML.

An official with the U.S. Army Medical
Research Institute of Chemical
Defence charged last month China is
the world leader in toxin “threats.”In
a 2015 academic paper, Shoham – of
Bar-Ilan’s Begin-Sadat Center for
Strategic Studies – asserts that more
than 40 Chinese facilities are involved
in bio-weapon production. China’s
Academy of Military Medical Sciences
actually developed an Ebola drug –
called JK-05 — but little has been
divulged about it or the defence
facility’s possession of the virus,
prompting speculation its Ebola cells
are part of China’s bio-warfare arsenal,
Shoham told the National Post.

James Giordano, a
neurology professor at
Georgetown University and
senior fellow in biowarfare
at the U.S. Special
Operations Command, said
it’s worrisome on a few
fronts. China’s growing
investment in bio-science,
looser ethics around gene-
editing and other cutting-
edge technology and
integration between
government and academia
raise the spectre of such
pathogens being
weaponized, he said.

Ebola is classified as a
“category A” bioterrorism
agent by the U.S. Centers for
Disease Control and
Prevention, meaning it could
be easily transmitted from
person to person, would result
in high death rates and “might
cause panic.” The CDC lists
Nipah as a category C
substance, a deadly emerging
pathogen that could be
engineered for mass
dissemination.

Nipah, which was first seen in Malaysia in 1998, has
caused a series of outbreaks across east and south
Asia, with death rates mostly over 50 per cent, and as
high as 100 per cent, according to World Health
Organization figures. It can cause encephalitis, an
often-fatal brain swelling, and has no known
treatment or vaccine.

The Johns Hopkins exercise — called Clade X — involved a
version of Nipah modified to be more easily passed between
people. America’s Blue Ribbon Study Panel on Biodefence
prefaced its 2015 report with a scenario involving the intentional
release of Nipah by aerosol spray.

China’s extensive and
controversial use of
CRISPR gene-editing
and weaponizing Biotechnol
ogy makes it conceivable
the country could bio-
engineer germs like Nipah
to make them even more
dangerous, Giordano said.

That could mean an offensive
agent, or a modified germ let loose
by proxies, for which only China
has the treatment or vaccine, said
Giordano, co-head of Georgetown’s
Brain Science and Global Law and
Policy Program.“This is not
warfare, per se,” he said. “But
what it’s doing is leveraging the
capability to act as global saviour,
which then creates various levels
of macro and micro economic and
bio-power dependencies.”

Asked if the possibility of the Canadian germs being
diverted into a Chinese bio weapons program is
connected to other upheaval at the microbiology lab,
Public Health Agency of Canada spokeswoman Anna
Maddison said this week the agency “continues to look
into the administrative matter.”

The agency divulged last week that it sent
samples of Ebola and henipavirus — which
includes Nipah and the related Hendra — to
China in March. It was meant for virus
research, part of the agency’s mission to back
international public-health research, a
spokesman said.

Last month, an acclaimed NML scientist — Xiangguo
Qiu — was reportedly escorted out of the lab along with
her husband, another biologist, and members of her
research team. The agency said it was investigating an
“administrative issue,” and had referred a possible policy
breach to the RCMP. Little more has been said about the
affair.

Dr. Xiangguo Qiu made at least five
trips over the school year 2017-18 to
the above-mentioned Wuhan National
Biosafety Laboratory of the Chinese
Academy of Sciences, which was
certified for BSL4 in January 2017.
The Wuhan National Biosafety
Laboratory is housed at the Chinese
military facility Wuhan Institute of
Virology linked to China’s Biological
Warfare Program. It was the first ever
lab in the country designed to meet
biosafety-level-4 (BSL-4) standards –
the highest biohazard level, meaning
that it would be qualified to handle
the most dangerous pathogens.

Moreover, in August 2017,
the National Health
Commission of China
approved research activities
involving Ebola, Nipah, and
Crimean-Congo hemorrhagic
fever viruses at the Wuhan
facility. Coincidentally, the
Wuhan National Biosafety
Laboratory is located only
20 miles away from the
Huanan Seafood Market
which is the epicenter of
the Coronavirus outbreak
dubbed the Wuhan
Coronavirus.
The Wuhan National Biosafety Laboratory is located
just about 20 miles away from the Huanan Seafood
Market, the epicenter of Coronavirus outbreak

In January 2018, the lab was operational ‘for global experiments on
BSL-4 pathogens,’ wrote Guizhen Wu in the journal Biosafety and
Health. ‘After a laboratory leak incident of SARS in 2004, the former
Ministry of Health of China initiated the construction of
preservation laboratories for high-level pathogens such as
SARS, coronavirus, and pandemic influenza virus,’ wrote Guizhen
Wu.

The Wuhan institute has
studied coronaviruses in the past,
including the strain that causes
Severe Acute Respiratory
Syndrome, or SARS, H5N1
influenza virus, Japanese
encephalitis, and dengue.
Researchers at the institute also
studied the germ that causes
anthrax – a biological agent once
developed in Russia.
“Coronaviruses (particularly
SARS) have been studied in the
institute and are probably held
therein,” said Dany Shoham, a
former Israeli military
intelligence officer who has
studied Chinese biowarfare. He
said. “SARS is included within
the Chinese BW program, at
large, and is dealt with in several
pertinent facilities.”

The PLA is pursuing military applications
for biology and looking into promising
intersections with other disciplines,
including brain science, supercomputing,
and artificial intelligence. Since 2016, the
Central Military Commission has funded
projects on military brain science, advanced
biomimetic systems, biological and
biomimetic materials, human performance
enhancement, and “new concept”

In 2016, an AMMS doctoral researcher published a dissertation, “Research on
the Evaluation of Human Performance Enhancement Technology,” which
characterized CRISPR-Cas as one of three primary technologies that might
boost troops’ combat effectiveness. The supporting research looked at the
effectiveness of the drug Modafinil, which has applications in cognitive
enhancement; and at transcranial magnetic stimulation, a type of brain
stimulation, while also contending that the “great potential” of CRISPR-Cas
as a “military deterrence technology in which China should “grasp the
initiative” in development.

In 2016, the potential strategic value of genetic information led the Chinese
government to launch the National Genebank, which intends to become the
world’s largest repository of such data. It aims to “develop and utilize China’s
valuable genetic resources, safeguard national security in bioinformatics, and
enhance China’s capability to seize the strategic commanding heights” in
the domain of Biotechnology Warfare.

Chinese military’s interest in biology as an
emerging domain of warfare is guided by
strategists who talk about potential “genetic
weapons” and the possibility of a “bloodless
victory.”

Meanwhile, in a very
strange turn of events,
renowned scientist Frank
Plummer who received
Saudi SARS Coronavirus
sample and was working
on Coronavirus (HIV)
vaccine in the Winnipeg
based Canadian lab from
where the virus was
smuggled by Chinese
Biowarfare agents has
died in mysterious
conditions in Nairobi,
Kenya.
Frank Plummer Assassination

Scholars or Spies
The Thousand Talents Plan or Thousand Talents Program was
established in 2008 by the central government of China to recognize
and recruit leading international experts in scientific research,
innovation, and entrepreneurship – in other words to steal western
technology.

Chinese Agent Charles
Lieber &
His Virus Transmitters

Dr. Charles Lieber is a nano-scientist
at Harvard University. He was
recently charged by the American
authorities for secretly being a
Chinese agent. However, there is a
mystery surrounding the nature of his
work. It is said he was recruited for
advanced research into nanowire-
batteries. Lieber was in fact working
on virus transmitters that could
penetrate cell membranes without
affecting the intercellular functions
and even measure activities inside
heart cells and muscle fibers.
Hyman professor of chemistry Charles Lieber has created a transistor so small it can be used to
penetrate cell membranes and probe their interiors, without disrupting function. The transistor
(yellow) sits near the bend in a hairpin-shaped, lipid-coated silicon nanowire. Its scale is similar to
that of intra-cellular structures such as organelles (pink and blue orbs) and actin filaments (pink
strand).

Dr. Charles Leiber is
a nano-scientist at
Harvard University
who also serves as a
chair for Harvard’s
Department of
Chemistry and
Chemical Biology.
He was arrested by
the U.S. Department
of Defense in
January for lying
about his association
with China’s
Thousand Talent
Program.
A V-shaped silicon nanowire is attached to bimetal connectors that lift the
entire structure up out of the horizontal plane on which it is made.

Dr. Charles Leiber is a nano-
scientist at Harvard University
who also serves as a chair for
Harvard’s Department of
Chemistry and Chemical Biology.
He was arrested by the U.S.
Department of Defense in
January for lying about his
association with China’s
Thousand Talent Program.
Once the nanowire has been lifted up, it
can penetrate three-dimensional
structures such as cells. B.Tian and C.M.
Lieber, Harvard University

It is basically a recruitment plan which
seeks to lure Chinese overseas talent
and foreign experts to bring their
knowledge and experience to China and
in return, reward individuals for stealing
proprietary information.

According to the charging
documents, Lieber was a
contractual participant of the
program and was paid $50,000
monthly, along with $158,000 in
living expenses and $1.74 million to
set up a research lab at Wuhan
University. The fact that Lieber
kept his association with the
Chinese a secret put his integrity in
question as well as financial
conflicts of interest, including
financial support from foreign
governments or foreign entities.
Although Lieber was released a day
later on a $1 million bond, the
question remains what exactly was
the nature of Leiber’s research.

What’s more concerning is that the affidavit released by the federal
prosecutors states that Leiber signed an agreement between Harvard
and Wuhan Insitute of Technology. According to the affidavit, the
purpose of the agreement was to “carry out advanced research and
development of nanowire-based lithium-ion batteries with high
performance for electric vehicles.”

However, things don’t add up since the focus of Leiber’s
research has never been about nanowire batteries. One
nanoscientist and former student of Lieber’s says: “I have never
seen Charlie working on batteries or nanowire batteries.” In
fact, in all his research papers and patents, there is no mention
of “batteries” or “vehicles”.

Dr. Leiber joined Harvard
in 1991. In his early days
at the university, he
made great strides in the
field by growing
nanowires in a flask.
Researchers before
Leiber were already
creating wire-like
structures with the help
of semiconductors, metals
and other materials.

However, their approach
would be quite expensive and
would need clean-room
facilities like the ones used by
computer chip-makers. In
contrast, Lieber could create
nanostructures using nothing
but simple and inexpensive
chemical techniques. He even
went a step further to show
how these nanowires could be
used as transistors, complex
logic circuits, data storage
devices, and even sensors.

In 2001, Harvard Magazine published a report that discussed Leiber and his
team’s research into what was termed as ‘Liquid Computing’. The report
mentioned how Leiber was at the forefront solving silicon-based microelectronics
industry’s greatest challenge – making silicon chips smaller and smaller. Leiber
noted that “continued shrinkage ultimately becomes problematic in terms of just
how one achieves [it].” Instead, he created tiny logic circuits and memory – the
two main components of a computer – using nanowires. And these circuits were
really tiny, some of which just a few atoms across!

Charles M. Leiber and his ‘Virus Transmitters’
Ten years later, Leiber created a transistor so
small it can be used to penetrate cell membranes
and probe their interiors, without affecting the
intercellular functions. The bio-compatible
transistor – the size of a virus – can not only
measure activities inside a neuron but also heart
cells and muscle fibers.

In 2017, Leiber and his
team successfully created
flexible 3D nanowires
mesh that can inject into the
brain or retina of an animal,
attach itself to the neurons
and monitor electrical signals
between the cells.
It’s no surprise the Chinese
officials were quick to get him
onboard considering he’s the
brightest brain when it comes
to nanotechnology. Not only
his research would have made
China an important player in
this futuristic technology but
it would also be a be a step
forward towards China’s
stated goal of Biological

The importance of
nanotechnology in
advanced
warfare can be
understood from
the fact that the
United States’
Department of
Defense (DoD) is
one of the largest
supporters of
nanotechnology
research. They have
funded hundreds of
millions of dollars
into various
research related to
nanoelectronics and

One can see why Charles Lieber’s secret association with the Chinese institutes and universities and his expertise in nanotechnology could
pose a serious threat. Lieber lied about his involvement with the Thousand Talents Plan and affiliation with the Wuhan Institute of
Technology and that makes him no less than a Chinese biowarfare agent.

The technology could help
create nanosensors and
nanocoatings that military
could use to protect soldiers
against chemical and
biological attacks. The fact
that nanosensors can detect
microscopic quantities of
chemicals means it can be
used as an effective early
warning system against
chemical warfare agents such
as nerve agents and blood
agents.

One can see why Charles
Lieber’s secret association
with the Chinese institutes
and universities and his
expertise in nanotechnology
could pose a serious threat.
Lieber lied about his
involvement with
the Thousand Talents
Plan and affiliation with the
Wuhan Institute of Technology
and that makes him no less
than a Chinese biowarfare
agent.

Another scientist who is key to
the COVID-19 investigation is
Dutch scientist Ron Fouchier.
Fouchier is a controversial figure in
the field of Viroscience. He is the
doctor who helped the Egyptian
doctor Ali Mohammad Zaki, who
isolated the coronavirus from the
dead Saudi businessman’s lungs, by
gene sequencing the sample sent by
Zaki. (mentioned in the beginning of
the report).
Dutch Virologist Ron Fouchier

He created world’s deadliest virus strain and his research sparked
a global controversy to de-fund and shutdown such experiments.
Experts have raised concerns legally that such experiments could
not only lead to a global pandemic but could also lead to bio-
terrorism. However, Ron Fouchier is also a key to the COVID-19
investigation. He isolated the SARS Coronavirus smuggled out of
Saudi Arabia which was sent to the Canadian scientist Frank
Plummer.

COVID-19 vaccine developed
by Wuhan institute set for
more clinical trials

1 A SUADI BUSINESSMAN DIES OF CORONA VIRUS
2 ALI MOHAMMAD ZAKI ISOLATED THE CORONAVIRUS
3 ZAKI SENDS RON FOUCHIER THE SAMPLES FOR STUDIES HE IDETIFIES IT AS
THE CORONAVIRUS AND SEQUENCES IT AND SMUGGLES IT OUT OF SAUDI
ARABIA.
4 FRANK PLUMMER RECIEVES THE VIRUS AND THEN STARTS WORKING ON THE
CURE(HIV) VACCINE IN CANADIAN NML.
5 CHINESE BIOSPY AGENTS DR. XIANGGUO QIU AND HER HUSBAND KEDING
CHENG WORKING ON THE SAME INSTITUTE STEAL THE VIRUS AND USE
FICTICIOUS RESEARCH PROGRAM TO TRANSFER THE VIRUS TO CHINESE
BIOWEAPONS LAB WUHAN INSTITUE OF VIROLOGY WHICH IS BSL-4 LAB.
FINAL SEQUENCE OF EVENTS
6 CHINESE AGENTS ASSASINATE DR FRANK PLUMMER WHO IS THE ONLY PERSON
OUTSIDE TO CREATE THE VACCINE TO CURE COVID-19

7 CHINA USES THE NANOROBOTS DEVELOPED BY THE CHARLES LIEBER TO
CREATE CONTROLLED OUTBREAK AND ALSO CONTROL THE SPREAD BY USING
THE VACCINE DEVELOPED BY DR PLUMMER TO PREVENT A NATIONWIDE
EPIDEMIC. THEY ALSO TARGET HIGH VALUE INDIVIDUALS.
8 THEY USE THEIR IMMIGRANT POPULATION TO CAREATE A GOLBAL PANDEMIC
WHILE WHO WHICH WAS PARTNER IN THE BSL4 LAB GIVES COVER ALL MAJOR
PHARMA COMPANIES HAVING MANUFACTURING BASE IN CHINA MAKE PROFIT
AND BLAME WUHAN SEAFOOD MARKET 20 MILES SOUTH OF WUHAN VIROLOGY
INSTITUTE FOR SPREAD.
9 BILL GATES DOES INFAMOUS VACCINE TESTS IN INDIA USING TRIBALS AS
GUINEA PIGS.
10 CHINAAND PHARMAAND MEDICAL COMPANIES MAKE SUPERNORMAL PROFITS
SELLING VENTILATORS, MASKS, GLOVES AND SLOW MOVING MEDICINES AT
THE COST OF MILLIONS OF LIVES

WIV has been in the eye of
the storm in recent weeks as
US President Donald Trump
and top American officials
alleged that the coronavirus
may have escaped from
there and demanded a probe
into it. An official of the WIV
denied it, terming the
allegation "entirely based on
speculation".

China has approved its third
coronavirus vaccine for the second
phase of clinical trials as it reported
12 new COVID-19 cases, taking the
total number of infections in the
country to 82,816. Meanwhile
China's National Health Commission
(NHC) said on Saturday that 12
newly confirmed COVID-19 cases
were reported in the country on
Friday, of which 11 were imported.

The overall confirmed cases
on the mainland had reached
82,816 by Friday, including
838 patients who were still
being treated and 77,346
people discharged after
treatment. The total number
of imported cases of the
coronavirus in China
increased to 1,629 on Friday;
of this, 909 had been
discharged from hospitals
after recovery, and 720 were
being treated with 25 in
severe condition.

China has approved three
coronavirus vaccines,
including the one developed by
the Chinese military, the
People's Liberation Army
(PLA), for clinical trials.
China has approved three
COVID-19 vaccine candidates
for clinical trials. An
adenovirus vector vaccine,
developed by Institute of
Military Medicine under the
Academy of Military Sciences,
was the first to be approved to
enter a clinical trial. The first
phase of the clinical trial was
completed at the end of
March, and the second phase
started on April 12.

China on Tuesday (April 14) said
it has given the go-ahead to two
more vaccine makers to carry out
early-stage human testing. They
are the Beijing subsidiary of
Nasdaq-listed Sinovac Biotech
and Chinese pharmaceutical
company Sinopharm together
with the Wuhan Institute of
Virology. Last month, Chinese
authorities approved clinical
trials for a vaccine candidate by
the People's Liberation Army's
Academy of Military Sciences and
biotech firm CanSino Bio, the
only vaccine in the world that last
week swiftly moved into the
second phase of a human trial.

Unlike the military-backed project, which is an adenovirus
vector vaccine, the two new candidates are inactivated vaccines
which provide weaker immunity than live vaccines. These are
the first two inactivated vaccines to start trial globally.

"It should be said that the production
process (for inactivated vaccines) is
relatively mature, the quality
standards are controllable, the scope
of protection is also relatively wide,"
said Ministry of Science and
Technology official Wu Yuanbin at a
news conference on Tuesday. "These
will provide some conditions for
accelerating the use of vaccines."

China has previously developed other
inactivated vaccines for H1N1,
hepatitis A, hand-foot-mouth disease
and polio. At least eight Chinese
institutes and companies are said to be
involved in the research and
development of a vaccine for Covid-19.
The asymptomatic cases were a cause of
concern as the government has lifted its
lockdown in Hubei and Wuhan after
cases abated. Asymptomatic cases refer
to people who are tested positive for the
coronavirus but develop no symptoms
such as fever, cough or sore throat.
They are infectious and pose a risk of
spreading to others.

China now has more COVID-19
vaccine candidates approved for
human testing than any other
country in the world. On
Tuesday, Chinese health
authorities approved vaccine
candidates developed by two
Chinese companies—the state-
owned Wuhan Institute of
Biological Products and the
Beijing-based biotech firm
Sinovac—for phase I testing on
humans, according to China’s
state-run media outlet Xinhua
News.

This follows an April 10 announcement that CanSino Biologics,
a biotech firm based in Tianjin, China, and its partners at the
Academy of Military Medical Sciences, were the world’s first
vaccine makers to move into phase II trials for vaccine
development.

China has thus far moved at
record speed in the global hunt
for a vaccine, China is
shortening the timeline for
seeing a vaccine through to
market. It's still working on
the 12- to 18- month
schedule that experts say is
realistic—if not overly
optimistic. At least three
companies based elsewhere
have entered phase I trials; a
fourth won phase I and phase
II approval at once. Yet the
Chinese companies are near
the pole position for vaccines
against the pandemic, and they
may gain more prominence as
candidates’ inch closer to the
finish line in coming months.

THE only explanation to the
feat is that they were not only
working to spike up the virus
but also developing the cure
for themselves and making the
trials for six long years from
2013 to 2019 using the
mountainous bats which are
the only mammals which have
the coronavirus inside body as
natural infections and this
have the naturally occurring
antibodies to the virus. The
actual trails are the human
trials for the antibodies proven
on the captured population
Xingang and Uighur provinces
camps. It has vast prison
population which it uses for
biological human tests as
human Guinea pigs.

An "inactivated" vaccine developed by
Wuhan Institute of Biological
Products under the China National
Pharmaceutical Group (Sinopharm)
and the Wuhan Institute of Virology
(WIV) started its clinical trials, state-
run Xinhua news agency reported. An
"inactivated" vaccine consists of virus
particles, bacteria, or other pathogens
that have been grown in culture and
then lose disease-producing capacity.
In contrast, live vaccines use
pathogens that are still alive.

The Chinese People's Liberation Army
(PLA) has completely controlled the
country's vaccine development program.
Currently, work is going on on 7 vaccine
candidates in the form of Human Trials all
over the world. 3 of these are with China
alone.
Mr Wu said China uses five approaches in
vaccine development: inactivated vaccines,
genetic engineering sub-unit vaccines,
adenovirus vector vaccines, nucleic acid
vaccines and vaccines using attenuated
influenza virus as vectors.
The Chinese Centre for Disease Control and
Prevention said on Jan 26 that the country
had started developing vaccines after the
virus was isolated and the seed strains
screened.

"We must be aware that the development of a vaccine is a battle that China cannot
afford to lose," said a Global Times op-ed last month." Future competition between
countries will be essentially a competition of technological strength. "Only by
mastering advanced technologies can a country be able to hold its development and
national security in its own hands. "From this aspect, it is not exaggerated to call
vaccine R&D a life-and-death battle."

Analysts say the Chinese
military has a distinct
advantage over the rest in the
development of vaccines, given
its access to samples and data,
and the complete backing of the
state.
A total of 96 persons in three
age groups have received the
vaccine in the first phase of
clinical trial as of April 23. The
vaccine has shown good safety
results so far and vaccine
receivers are still under
observation, said the Chinese
pharmaceutical company
Sinopharm.

The randomised, double-blind,and placebo-controlled clinical trials of
the inactivated vaccine are conducted in Jiaozuo, central China's
Henan Province, and the second phase of clinical trials will focus on
the vaccination procedure, it said. The vaccine will also go through the
third phase of the clinical trial, and it may take about one year to
complete the clinical trial before finally reaching the conclusion on the
vaccine's safety and efficacy, it said.

The Chinese vaccine has been undergoing trials since March 16 in
Wuhan, the birthplace of the corona virus. The researcher claimed
that the vaccine was undergoing a proper trial in Wuhan. The result
will be announced in April. This vaccine will be tested on foreigners
based in China. Researcher Chen of the Chinese Military Science
Academy said that this vaccine would be used in other countries
affected by Corona.

Pakistan is going to become a Guinea pig for the China Covid-19 Vaccine on
Pakistan, which is suffering from the coronavirus. Pakistan has allowed China
to test its vaccine (Covid-19 Vaccine) on humans. This test will be done in the
next three months. China has created a vaccine to deal with the corona virus
which will be tried in Pakistan. Through this, China will try to know how
effective the vaccine is and not its side effects. Actually, China is going to
conduct clinical trials of its vaccine in Pakistan on corona patients

Pakistan is going to become a Guinea pig for the China Covid-19 Vaccine on
Pakistan, which is suffering from the coronavirus. Pakistan has allowed China to
test its vaccine (Covid-19 Vaccine) on humans. This test will be done in the next
three months. China has created a vaccine to deal with the corona virus which will
be tried in Pakistan. Through this, China will try to know how effective the vaccine
is and not its side effects. Actually, China is going to conduct clinical trials of its
vaccine in Pakistan on corona patients

“We will be part of clinical trial with
China,” said ED NIH Maj Gen Aamer
Ikram to The Nation. In a letter written
to the Sinopharm International, ED
NIH said that that “our two
organizations have already been
collaborating in vaccine development in
Pakistan. Through our representative
Health Bee projects private limited, we
would like to extend our offer for
cooperation on conducting clinical trials
of our recently developed inactivated
Covid-19 vaccine to the National
Institute of Health in our brotherly
country, Pakistan”.

Interestingly, this pharma company is
not yet listed under the WHO's
Important Candidate Vaccine List. In
this case, raising doubts about the safety
of the proposed trial.
Speaking to Pakistan News Channel 92
News, Major General Doctor Aamir
Ikram of Pakistan's National Institute of
Health said that China has started work
for the vaccine trial. He said, "It is
expected that the corona virus vaccine
will be launched in Pakistan in the next
three months."

'Recognition of new Chinese-made
vaccine from many institutions'.
Ikram said that many companies
are trying to make vaccines, but
China has discovered this. He
said, 'It usually takes 8 to 10
years to make a vaccine. The new
Chinese-made vaccine has been
recognized by many institutions.
We will fix all these cases very
soon. ' In fact, China is going to
conduct its own clinical trial in
Pakistan on patients with corona
virus. There is a great risk of
trials on humans of any vaccine.
The patient's life can also be lost.
The disease can spread more.

Farhanaz Ispahani, a Global Fellow
of Woodrow Wilson, Washington, has
questioned China's intention behind
the move. She wrote on Twitter that
human guinea pig? Would the Prime
Minister who did not have the
wisdom or the will to close the
mosques of the country, not be able to
ask China for this?
Despite all these dangers, the Imran
Khan government of Pakistan has
agreed to put the lives of citizens at
stake to please China. Earlier China
had announced that it would now
test its vaccine in other countries of
the world. Earlier, a Chinese
researcher said that China is making
a vaccine and plans to conduct
clinical trials in other countries
affected by Corona.

Sinopharm, HealthBee and NIH finalising agreements to kick start
trials
The letter said that “PRC(Peoples Republic of China), Phase-I & Phase
–II for clinical trial have been combined. We recommend and hope that
Pakistan will adopt a similar approach through its regulatory
authority. We hope that successful clinical trial in Pakistan will make
it one of the few countries for the launch of Covid-19 vaccine”.

However, a pharmacist and former secretary biological drugs of DRAP Dr. Obaid
Ali viewed that disclosure of preclinical data to demonstrate safety of human trial
should be the first priority. He said that preclinical and clinical risk mitigation
strategies need to be in place, so that those enrolled in clinical trials may not
experience to any potential unreasonable risk that can be avoided. “Data is
required to evaluate theoretical risk for vaccine-induced conditions, which may be
worse if subject catches infection in real time during trial,” he said.

Meanwhile the GM China Sinopharm International Corporation Li Can,
writing to NIH about the tripartite Memorandum of Understanding
(MoU) said that with reference of previous correspondence through the
embassy of PRC with Maj. Gen Dr. Aamir Ikram at National Institute of
Health (NIH), Sinophrm considers that NIH has the necessary technical
expertise and elements for conducting the clinical trial on recruited
participants, through a nominated medical institutions, under Phase-I
and II protocol requirements and as per clinical trial guidelines.

It said that in order to achieve the objective, we
recommend that Sinopharm, HealthBee and
NIH enter into tripartite MOU urgently to plan
and commence the implementation of these
Phase I and II combined clinical trials. This
will enable Sinnopharm to share more detailed
confidential information for approvals and
planning.

It also said that NIH is
requested to first kindly
facilitate the approval of the
Ministry of National Health
Services and Drug Regulatory
Authority of Pakistan (DRAP)
for the clinical trial. We believe
that the MOU will expedite the
local documentation, regulatory
approvals process as well as help
clearly identify the roles of
various entities involved. “Given
the escalating spread of the
pandemic, urgency is critical to
the launch of any clinical trial in
Pakistan and the subsequent
introduction of the vaccine in
Pakistan,” said the letter.

It further said that through our representative
HealthBee Projects Private Limited we will
provide full support in the provision of the
supporting/regulatory documentation,
distribution of trial related funding, planning of
logistics, and submission of clinical trial dossier
to DRAP.

It added “we will work in
collaboration with MIH clinical trial
team and during the processing for
the success of clinical trials as this
endeavour is of utmost importance
for our countries in accordance with
the current pandemic situation”. The
letter said will be grateful if an in-
principal approval for our
cooperation can be provided to us
before progressing further. We look
forward for your kind support and
urgent response, after consulting the
relevant ministries of the
government of Pakistan.

If clinical trials are conducted in Pakistan
and it turns out successful, then it will be
the first nation to get the vaccine on high-
priority basis.
A Pakistani television journalist has claimed
that China has developed a vaccine for
covid-19 and Pakistan will be among the
first few countries to receive it. Even as the
scientists across the globe are working
overtime to find a cure and vaccine for the
covid-19 pandemic, In her program, a letter
claiming that this so-called vaccine program
would take 3 months minimum to start its
trials. The letter states that the company
has offered to do clinical trials on patients in
Pakistan first.

It also mentions that China's request for
clinical trials and recruitment of test-
patients for phase 1 and 2 tests. According
to the claims, if clinical trials are
conducted in Pakistan and it turns out
successful, then it will be the first nation
to get the vaccine on a high-priority basis.
We would like to inform our viewers that
nowhere in the world has a vaccine for the
coronavirus been developed yet. It takes
several phases of clinical trials before
scientific communities declare a vaccine
safe for human use.

Now let us look at the companies at the forefront of the efforts: -

CanSino Biologics was founded
in 2009 by Yu Xuefeng, a
Chinese national who spent
most of his career in Canada
working for the vaccine and
pharmaceutical giant Sanofi
Pasteur. Yu says that he
founded the company to connect
what he saw as a booming
vaccine research and
development market in China
with international markets and
collaborators. In line with this
mission, he recruited three
other native-Chinese scientists
with overseas pharmaceutical
experience to launch the
company.
CanSino Biologics

CanSino has worked on
developing vaccines for a
number of different
infectious diseases, such
as meningitis and
tuberculosis. It was thrust
into China’s national
spotlight in 2017
when domestic authorities
approved the company’s
vaccine as China's first
candidate for Ebola. The
vaccine was developed in
partnership with the
military-run Academy of
Military Medical Sciences
in Beijing.

CanSino has worked on developing vaccines for a number of different
infectious diseases, such as meningitis and tuberculosis. It was thrust
into China’s national spotlight in 2017 when domestic authorities
approved the company’s vaccine as China's first candidate for Ebola.
The vaccine was developed in partnership with the military-run
Academy of Military Medical Sciences in Beijing.

Yu has signalled openness in
cooperating internationally in
finding a vaccine, and on Monday
signed on to a World Health
Organization statement urging more
global coordination in COVID-19
vaccine development efforts. At the
same time, Dr. Chen Wei, a Chinese
general who is leading the military
vaccine team partnering with
CanSino, has described the quest
in militaristic and nationalistic
terms, equating finding a vaccine
with providing China a 'bio
shield' from outside threats.
CanSino says its current vaccine
efforts are based on the
technologies it developed in
producing the Ebola vaccine, and
Chinese media has heralded the
company’s efforts as a
demonstration of the
country’s "strong research
capabilities."

Sinovac Biotech
Sinovac Biotech was established in
Beijing in 2001 on the heels of work
conducted by CEO Yin Weidong and
his team to develop China’s first
domestically-produced hepatitis A
vaccine. Since then, the company
has developed six other
commercially-viable vaccines, and
the firm now has a market value
of over $400 million
The company gained particular
prominence in 2009 when it
developed the world’s first approved
vaccine to tackle H1N1 swine flu,
the only pandemic the world had
grappled with since the 1918
Spanish Flu until the coronavirus
hit.

Sinovac’s efforts to produce a
coronavirus vaccine are based on
platforms the company used to
address China’s Severe Acute
Respiratory Syndrome (SARS)
epidemic in 2004, according to
a vaccine tracker run by the Milken
Institute, a U.S.-based think tank. At
the time of SARS, Sinovac created the
first vaccine candidate to enter human
trials. And though initial trials proved
promising, further trials were
suspended as the threat of SARS
subsided.
For now, the company seems intent to
showcase to the world that coronavirus
isn’t the first pandemic it's battled.
“Sinovac has always been committed
to developing vaccines for global use
when facing pandemics,” Yin said in a
company statement on Tuesday.

Less is known about the Wuhan
Institute of Biological Products.
Founded in 1950, it traces its
roots almost all the way back to
the founding of modern-day
China. The institute now
operates as an affiliate of the
state-owned China National
Pharmaceutical Group—also
known as Sinopharm—which is
the largest pharmaceutical
company in China with annual
revenue topping $60 billion in
2019. The institute has a
sprawling campus in Wuhan with
nearly 1,000 employees,
according to the company’s
website. The company, however,
has released little information
about its past or ongoing vaccine
Wuhan Institute of Biological Products

Located in the city at the centre of China's coronavirus
outbreak, the institute has become the subject of unfounded
conspiracy theories that suggest the pathogen leaked from its
labs. Such theories have largely targeted the Wuhan Institute
of Virology, but some have drawn connections between the two
institutes, inserting them into the unproven narrative that the
Chinese government played a role in creating the virus. The
U.S. government is currently investigating the possibility that
the virus originated in a lab but hasn't yet drawn any
conclusions. Scientists say that the virus most likely started
in bats and spread to other animals before passing to humans,
but its specific origin is not yet known.

The Institute of Biological
Products has had to
overcome a scandal of a
different kind in recent
years. In 2018, the
Chinese government
found that the institute
produced over 400,000
defective DPT
vaccines—which protect
against diphtheria,
pertussis, and
tuberculosis—and
sacked six local
government officials in
the wake of the crisis.

This is a robotic dragonfly. it
was developed by the CIA and
was flying in the 1970s. It
was powered by an
ultraminiaturized gasoline
engine (!) that would vent its
exhaust backwards to
increase the bot’s thrust, and
the only reason they seemed
to have scrapped it was that
its performance in a
crosswind wasn’t that good. A
laser beam steered the
dragonfly and a watchmaker
on the project crafted a
miniature oscillating engine
so the wings beat, and the
fuel bladder carried liquid
propellant.
MICROROBOTICS SPREAD AND CONTROL

This was the state of technology 40 years ago versus the state of
technology today, and what might be possible now (but currently top
secret) if they had an operational insect robot way back then.

Animal Dynamics,
a British startup
spinoff from Oxford
University,
produces
biologically inspired
vehicles and drones
— including the
dragonfly-inspired
“Skeeter,” a drone
the size of a pen
intended for
military
reconnaissance.

Thomas, the co-founder and
chief science officer of
Animal
Dynamics, studies biomecha
nics — how animals fly and
move. The company’s 44
employees, $8 million in
venture capital and
contracts with the British
Ministry of Defense
signal the increasing
attention on bio-inspired
design. Animals have been
moulded by millennia of
evolution to become as
efficient as possible, an
urgent mission for the
nonorganic world in an era
of climate change. Today,
Animal Dynamics has three
projects underway.

The Skeeter is an
insect like autonomous
drone for military
reconnaissance. The
Stork is the most
advanced model, a
paraglider-like drone
that can efficiently
glide into military
resupply drops. The
Malolo is a waterborne
craft that propels itself
with a finlike device
instead of a propeller.

China is deploying robots and drones to remotely disinfect hospitals, deliver
food and enforce quarantine restrictions as part of the effort to
fight coronavirus. Chinese state media has reported that drones and robots
are being used by the government to cut the risk of person-to-person
transmission of the disease. There are 780 million people that are on some
form of residential lockdown in China. Wuhan, the city where the viral
outbreak began, has been sealed off from the outside world for weeks. There
have also been reports of drones using thermal imaging to detect people
with fevers from the air. These viral videos could "absolutely be real" said
drone expert Andy Miah, "I think they're an incredibly appealing tool for
the law enforcement industry," Miah told Dezeen.

"The drone gives the police
force a capacity to roam and be
present in a way that no other
means of movement have
allowed in the past." futuristic
technology powered by
artificial intelligence is helping
to identify coronavirus
symptoms, find new
treatments, and track the
spread of the disease.
Meanwhile, robots are making
interactions with and
treatment of sick patients
easier.

Powerful surveillance tech — including
facial recognition-enabled cameras and
drones — is also helping find people who
might be sick or who aren’t wearing
masks. Flying robots, also known as
drones, are also in the mix. Shenzhen
Micro-Multi-Copter said in a statement
earlier this month that it is
deploying drones to patrol public places,
spray disinfectant, and conduct thermal
imaging. Chinese officials have used
drones to track whether people are
traveling outside without wearing face
masks or violating other quarantine
rules. More on this surveillance trend in a
second.

Coronavirus is contagious and hard to contain, which means that it’s safer for many
human-to-human interactions to be done remotely. Both in hospitals and in public,
remote communication means that patients avoid transmitting the disease and health
workers save time on simple tasks. This has cleared the way for robots and lots of other
automated technologies to help out. Now, robots are being used to disinfect
rooms, communicate with isolated people, take vital information, and deliver medications
(and anything else someone might need).

Public health data
surveillance companies
Metabiota and BlueDot were
both used to track the initial
outbreak of the novel
coronavirus. BlueDot
actually notified its clients of
the coronavirus threat
several days before both the
World Health Organization
and the Centers for Disease
Control and Prevention
(CDC) issued their public
warnings. Now, the same
type of technology continues
to monitor social media posts
and other publicly available
content to look for signs of
the disease’s spread,
as Wired has reported.

Companies that sell facial
recognition are using the
outbreak as an opportunity to
push their own tech’s
capabilities.
As Quartz reported, China’s
Sense-Time now boasts that
its software can identify
people without face masks on.
And on Twitter, at least one
company — Remark Holdings
— cited the coronavirus while
pushing that its software’s
ability to detect whether
people were wearing masks
was better than that of
Chinese company Baidu.

Baidu, the Chinese search engine giant, has made
its computing capabilities available to scientists for
studying the virus. According to the company, its
algorithm multiplies the sequencing speed by
20 . Several research teams are also working on an
AI capable of mapping and predicting the spread of
the virus . Tencent and Baidu provided their users'
data to model how the virus was able to
leave Wuhan in the days following its
appearance. Other algorithms scan social
networks, media reports and official health data to
determine where the virus is most likely to
spread. For its part, the Chinese start-up iFlytek
has developed an algorithm to identify the patients
most at risk according to their age, place of
residence or medical condition.

This more advanced facial recognition tech already exists.
Panasonic, which is also selling its facial recognition
system FacePro in the US, has also claimed that its
systems can identify people wearing masks. The
coronavirus epidemic has also inspired facial recognition
companies to integrate their tech with thermal imaging.

SenseTime is selling thermal imaging-enabled facial recognition, and
so is Sunell, another China-based video surveillance company,
according to a press release. Proponents of surveillance tech focus on
threats to peoples’ safety and property, pointing to “dangerous” people
like terrorists and sex offenders. Less often, however, do proponents of
this technology point to the safety risks associated with a potential
pandemic.

In the Beijing metro, travellers are scrutinized by
an infrared scanner that measures their
temperature. Developed by Megvii,
a Chinese start-up, "the system is able to
accurately detect a body temperature at distances
greater than 3 meters and in the midst of heavy
passenger traffic, even when the person is wearing
a mask or a hat,” says the company. The passenger
is then identified by facial recognition.

"This allows staff to
carry out checks
without physical conta
ct close, while reducing
the potential
transmission of the
coronavirus and
optimizing the flow of
passengers ”. Its
competitor Baidu has
developed a similar
system, capable of
detecting the
temperature of 200
people per minute,
faster than the
scanners used in
airports.

Viral outbreaks like COVID-19 highlight the growing
role new medical technology — in particular, ideas
from the field of robotics — can play in fighting the
spread of novel infectious diseases.

“Extreme cases make us rethink how we do things,” says Dr.
Robin Murphy, Raytheon professor of computer science &
engineering at Texas A&M University. The 2014 Ebola outbreak
in Texas, the first in the U.S., led to years of study by Murphy and
others on emergency response and the integration of robotics with
medicine to help limit pathways for a highly contagious disease to

“A hospital lost a whole wing
temporarily. Two ambulances
were infected,” she recalled.
Still, she says, not enough has
changed. Wild ideas from the
world of robotics capture
attention, but health-care
experts like Murphy are
focused on more basic
automated solutions, like
seeing robots perform routine
medical work for contagious
patients, without replacing or
eliminating health-care
workers, to free up medical
staff so they can spend more
time on direct care, as well as
reduce risk of their exposure.

Hospital beds that can be
automated to cycle
through a series of
positions (e.g., elevate
head for X amount of
time, then lower and
elevate Y) can perform
work that is difficult to do
for health-care
professionals while they
are wearing protective
gear and focused on
higher-priority items.

“The medical professionals said they were always behind,”
according to Murphy, but this was one task that Ebola workers
found did provide patient benefits. Robots designed for handling
biohazardous waste and decontaminating rooms and ambulances
are also ideas born out of an era of increasing experience with
pandemic risks.

“Why waste a person
carrying the trash?
Why send a nurse in
to change a position
on the bed. Now we’re
not thinking of the
robots as things that
look like a dog or
humanoids — think of
the bed itself as being
a robot,” Murphy said.

Stanford Medical Center IV bags are
wirelessly connected to a network and
can be remotely programmed — an IV
bag Internet of Things — though the
system does not include the robotic
changing of bags that Murphy
envisions. Beds from Leaf Healthcare
used in the Stanford hospital are able
to inflate or deflate to reposition
patients and avoid pressure injuries.
UV sterilizing robots from Xenex are
used in highly contagious infection
rooms where virulent organisms are
present. “I have a feeling in time that
may become standard,” Damrose said.
“Look at the antibiotic crisis and how
these organisms are adapting to
disinfectants and antibiotics. It doesn’t
make sense to hand clean a room.
Rooms of the future could all have UV
cleaning robots.”

The ability to incorporate such dual-use cyberinsects and biorobots in the
potential weaponization of biological agents needs to be addressed and
curbed. Biorobots of the household pest the cockroach, Blaberus discoidalis,
the desert ant Cataglyphis, and the cricket- Gryllus bimaculatus are already
the subject of in situ research. The cricket robot is being developed, in the
USA, through academic research within the framework of the Defence
Advanced Research Projects Agency (DARPA) robotics program.

Nanotechnology has potential
applications for defence, especially
in the field of sensors, transducers,
nanorobotics, nanoelectronics,
memory storage, propellants, &
explosives to enhance the
performance of devices and weapon
systems. The research and
development activities of
nanotechnology are increasing
globally at a rapid rate. Many
programs have been launched by
individual countries or jointly
towards the realization of
nanotechnology.

Weapons of mass destruction, be they nuclear, chemical or biological in nature,
constitute a threat to national security, and to regional and international co-
operation (New York Academy of Sciences, 1998). Civilian and military
vulnerability to biological weapons can be overcome by resorting to the
development of biosensors, fast-reacting bio-detection agents, advanced medical
diagnostics, and effective vaccination and immunisation programmes. Bio -
detection has been spurred on through the development of biorobots (Treindl,
1999). Mechanised insects with computerised artificial systems mimic through
microchips or biochips certain biological processes such as neural networks that
gather and process neural impulses that influence behavioural sensitivities to
stress and dangerous responses to substances of biological and chemical origin.
These micro-gadgets can carry out in a single operation tasks such as DNA
processing, screening of blood samples, scans for the presence and identifications
of disease genes, and monitoring of genetic cell activity normally carried out by
several laboratory technicians.

Researchers have long
dreamed of developing tiny
robots that could roam about
inside our bodies, delivering
drugs with unprecedented
precision, and hunting down
and destroying cancer cells.
Last month scientists from
China’s National Center for
Nanoscience and Technology
(NCNT) and Arizona State
University said they had
developed robots a few
hundred nanometers across —
there are 25 million
nanometers in an inch — and
when they injected them into
the bloodstream of mice,
the nanorobots could shrink
tumors by blocking their blood

The nanorobots were made
from sheets of DNA rolled into
tubes containing a blood-
clotting drug. On the outside,
the researchers placed a small
DNA molecule that binds with
a protein found only in tumors.
When the bots reached tumors,
this molecule attached to the
protein, triggering the DNA
tube to unroll and release the
drug. Such a device is very
different from the human-scale
bots that build our cars and
vacuum our floors. But
Guangjun Nie, one of the
NCNT professors who
developed the nanorobots,
points out that they are able to
sense their environment,
navigate, and carry out
mechanical tasks just like
large robots.

The researchers are working
with a biotech firm to
commercialize the cancer-
fighting nanobots. And Nie
says this is just a taste of what
DNA nanorobots could do.
“What we call nanorobots are
the next generation of
nanomedicines because they
give you much better control
and can be made to work like a
machine,” he says. "In the
future we will demonstrate
even more scenarios for our
nanorobots from monitoring
disease, to finding tissue
damage, curing cancer and
maybe even finding and
destroying plaques in our blood
vessels."

In addition to boosting the
effectiveness and lessening
the side effects of powerful
drugs, nanorobots loitering in
our bloodstream could act as
early warning systems for
disease. And tiny wireless
surgical tools could let doctors
perform medical procedures
without cutting people open.
Eric Diller, an assistant
professor of mechanical
engineering at the University of
Toronto in Canada, is working
on this last problem. He’s
developing robots just under a
millimetre across that are built
from elastic polymers filled
with magnetic particles that
can be dragged through fluids
and triggered to grasp objects.

These tiny bots are controlled by
precise magnetic fields generated by
an array of electromagnets. The
robots could eventually be used to
collect tissue biopsies or carry drug
capsules inside the body, says Diller.
The nanorobots operate in a virtual
environment comparing random,
thermal and chemical control
techniques. The nanorobot
architecture model has
nanobioelectronics as the basis for
manufacturing integrated system
devices with embedded
nanobiosensors and actuators, which
facilitates its application for medical
target identification and drug
delivery. The nanorobot interaction
with the described workspace shows
how time actuation is improved
based on sensor capabilities.

Therefore, our work addresses the
control and the architecture design
for developing practical molecular
machines. Advances in
nanotechnology are enabling
manufacturing nanosensors and
actuators through
nanobioelectronics and biologically
inspired devices. Analysis of
integrated system modeling is one
important aspect for supporting
nanotechnology in the fast
development towards one of the
most challenging new fields of
science: molecular machines. The
use of 3D simulation can provide
interactive tools for addressing
nanorobot choices on sensing,
hardware architecture design,
manufacturing approaches, and
control methodology investigation.

The ability to manufacture nanorobots can be understood as the result of current
trends and new methodologies in fabrication, computation, transducers and
manipulation. The hardware architecture for a medical nanorobot must include
the necessary devices for monitoring the most important aspects of its operational
workspace: the human body. To reach this aim, data processing, energy supply,
and data transmission capabilities should be addressed through embedded
integrated circuits, using advances in technologies derived from nanotechnology
and VLSI design.

CMOS VLSI design using extreme
ultraviolet lithography provides
high precision and a commercial
way for manufacturing early
nanodevices and nanoelectronics
systems. To validate designs and to
achieve a successful
implementation, the use of VHDL
(very high-speed integrated circuit
hardware description language) has
become the most common
methodology utilized in the
integrated circuit manufacturing
industry. A large set of different
chemical and biological sensors has
been achieved with distinct
sequences of peptides through
combinatorial chemistry for
selective detection of various
medical targets.

For example, nano-
biosensors and
fabrication processes on
nanoelectronics have
been investigated and
established to achieve
electrochemical
activation at nanoscale
environment

coronavirus bioweapon.pptx

Recommended

Recommended

More Related Content

Similar to coronavirus bioweapon.pptx

Similar to coronavirus bioweapon.pptx (20)

More from devmarineacademy

More from devmarineacademy (20)

Recently uploaded

Recently uploaded (20)

coronavirus bioweapon.pptx